Evidence map›Paper›PMID 36859298›Full record

ArticleBMC medical education2023

Evaluation and guide for embedding opioid use disorder education in health professions' curricula.

Julie G Salvador, Sindy L Bolaños-Sacoman, Joanna G Katzman, Ann E Morrison, Lindsay E Fox, Jennifer S Schneider, Snehal R Bhatt, Tyler W Kincaid, V Ann Waldorf

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical education, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Julie G SalvadorHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA. jgsalvador@salud.unm.edu.
Sindy L Bolaños-SacomanSBS Evaluation & Program Development Specialists, LLC, Albuquerque, NM, USA.
Joanna G KatzmanHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
Ann E MorrisonHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
Lindsay E FoxHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
Jennifer S SchneiderHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
Snehal R BhattHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
Tyler W KincaidHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
V Ann WaldorfHealth Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
University of New Mexico · US

Funding

SAMHSA HHS 6H79TI081652
6 · The paper itself

Abstract

backgroundMorbidity and mortality from Opioid Use Disorder is a health crisis in the United States. During the COVID-19 pandemic, there was a devastating increase of 38.4% in overdose deaths from the 12-month period leading up to June 2019 compared with the 12-month period leading up to May 2020, primarily driven by synthetic opioids. Buprenorphine is an effective medication for opioid use disorder but uptake is slow due in part to lack of provider knowledge, confidence, and negative attitudes/stigma toward patients with OUD. Addressing these barriers in academic training is a promising approach to building workforce able to effectively treat opioid use disorder.

methodsOur university developed a training for pre-licensure physicians, physician assistants and psychiatric nurse practitioners that included the DATA Waiver training and a shadowing experience. Expected outcomes included improved knowledge, skills and attitudes about persons with OUD and buprenorphine treatment, plans to provide this treatment post-graduation, for pre-licensure learners to have completed all requirements to prescribe buprenorphine post-graduation, and for the training to be embedded into school's curricula.

resultsResults were positive overall including improved knowledge and attitudes toward persons with OUD, better understanding of the benefits of this treatment for patients, increased confidence and motivation to provide this treatment post-graduation. The training is now embedded in each program's graduation requirements.

conclusionDeveloping a didactic and experiential training on buprenorphine treatment for opioid use disorder and embedding it into medical, physician assistant, and psychiatric nurse practitioner licensure programs can help prepare future providers to treat opioid use disorder in a range of settings. Key to replicating this program in other university settings is to engage faculty members who actively provide treatment to persons with OUD to ensure shadowing opportunities and serve as role models for learners.

Indexed as

BuprenorphineCOVID-19Opioid-Related DisordersCurriculumHealth OccupationsHumansPandemicsBuprenorphineBuprenorphine trainingHealth professional trainingOpioid treatment

Identifiers

PMID36859298
PMCPMC9975819
OpenAlexW4322741341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.